| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2005Sci...310..674M |
| P356 | DOI | 10.1126/SCIENCE.1118476 |
| P698 | PubMed publication ID | 16254184 |
| P50 | author | Petr Broz | Q37378371 |
| P2093 | author name string | Guy R Cornelis | |
| Isabel Sorg | |||
| Andreas Engel | |||
| Shirley A Müller | |||
| Philippe Ringler | |||
| Catherine A Mueller | |||
| Françoise Erne-Brand | |||
| Marina Kuhn | |||
| P433 | issue | 5748 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 674-676 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles | |
| P478 | volume | 310 |
| Q41435019 | A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia |
| Q36833082 | A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact |
| Q39028285 | A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice |
| Q38127453 | A sophisticated multi-step secretion mechanism: how the type 3 secretion system is regulated |
| Q37673260 | Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone/usher machinery: structure and function from a clinical standpoint |
| Q33636983 | Amino acid and structural variability of Yersinia pestis LcrV protein. |
| Q33653622 | Amino acid residues 196-225 of LcrV represent a plague protective epitope |
| Q41380601 | Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa |
| Q38366322 | Approaches targeting the type III secretion system to treat or prevent bacterial infections |
| Q37230906 | Architectures and biogenesis of non-flagellar protein appendages in Gram-negative bacteria |
| Q41411817 | Assembly of the Yersinia injectisome: the missing pieces. |
| Q38183945 | Assembly of the bacterial type III secretion machinery. |
| Q33238585 | Assembly of the type III secretion apparatus of enteropathogenic Escherichia coli |
| Q39230405 | Assembly, structure, function and regulation of type III secretion systems. |
| Q34142106 | Bacterial nanomachines: the flagellum and type III injectisome. |
| Q58792122 | Bacterial type III secretion systems: a complex device for the delivery of bacterial effector proteins into eukaryotic host cells |
| Q27028058 | Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells |
| Q53028079 | Binding mode analysis of a major T3SS translocator protein PopB with its chaperone PcrH from Pseudomonas aeruginosa. |
| Q28484742 | Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis |
| Q34851073 | Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein |
| Q39177635 | Biophysical characterization of the type III secretion tip proteins and the tip proteins attached to bacterium-like particles |
| Q33590435 | Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN |
| Q43422418 | Characterization of molten globule PopB in absence and presence of its chaperone PcrH. |
| Q30428389 | Characterization of the interaction between the Salmonella type III secretion system tip protein SipD and the needle protein PrgI by paramagnetic relaxation enhancement |
| Q36388232 | Conformational stability and differential structural analysis of LcrV, PcrV, BipD, and SipD from type III secretion systems |
| Q35071514 | Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV. |
| Q27671650 | Crystal Structure of PrgI-SipD: Insight into a Secretion Competent State of the Type Three Secretion System Needle Tip and its Interaction with Host Ligands |
| Q30481246 | Cytoplasmic targeting of IpaC to the bacterial pole directs polar type III secretion in Shigella |
| Q80295328 | Deadly plague versus mild-mannered TLR4 |
| Q30494891 | Deciphering the assembly of the Yersinia type III secretion injectisome |
| Q92726819 | Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis |
| Q35783560 | Development of in vitro correlate assays of immunity to infection with Yersinia pestis. |
| Q33388949 | Differentially evolved genes of Salmonella pathogenicity islands: insights into the mechanism of host specificity in Salmonella |
| Q36315321 | Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence |
| Q33601814 | Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV |
| Q37450884 | Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague |
| Q33965276 | Efficient isolation of Pseudomonas aeruginosa type III secretion translocators and assembly of heteromeric transmembrane pores in model membranes |
| Q90186755 | Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens |
| Q35913680 | Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis |
| Q30481673 | ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa |
| Q35970485 | Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles |
| Q41429434 | Expression hierarchy in the Yersinia type III secretion system established through YopD recognition of RNA |
| Q35846730 | Expression, limited proteolysis and preliminary crystallographic analysis of IpaD, a component of the Shigella flexneri type III secretion system |
| Q41448848 | Extracytoplasmic-stress-responsive pathways modulate type III secretion in Yersinia pseudotuberculosis |
| Q36852090 | FGL chaperone-assembled fimbrial polyadhesins: anti-immune armament of Gram-negative bacterial pathogens |
| Q90168522 | FPR1 is the plague receptor on host immune cells |
| Q33877252 | Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice |
| Q41432317 | Formulation and Immunogenicity of a Potential Multivalent Type III Secretion System-Based Protein Vaccine |
| Q41447558 | Function and molecular architecture of the Yersinia injectisome tip complex |
| Q39192014 | Functional insights into the Shigella type III needle tip IpaD in secretion control and cell contact. |
| Q38725248 | Functional relatedness in the Inv/Mxi-Spa type III secretion system family |
| Q26995596 | Förster resonance energy transfer (FRET) as a tool for dissecting the molecular mechanisms for maturation of the Shigella type III secretion needle tip complex |
| Q42736388 | Genetic Dissection of the Signaling Cascade that Controls Activation of the Shigella Type III Secretion System from the Needle Tip. |
| Q40710120 | Genome Sequence of the Fish Pathogen Yersinia ruckeri SC09 Provides Insights into Niche Adaptation and Pathogenic Mechanism |
| Q33691879 | Glutathionylation of Yersinia pestis LcrV and Its Effects on Plague Pathogenesis |
| Q35913579 | Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10. |
| Q36410035 | Hereditary hemochromatosis restores the virulence of plague vaccine strains |
| Q54242376 | Heterologous Complementation Studies With the YscX and YscY Protein Families Reveals a Specificity for Yersinia pseudotuberculosis Type III Secretion. |
| Q33304193 | High throughput screening for small-molecule inhibitors of type III secretion in Yersinia pestis |
| Q33778441 | Hijacking of the pleiotropic cytokine interferon-γ by the type III secretion system of Yersinia pestis |
| Q34660429 | How the structural gene products of Yersinia pestis relate to virulence |
| Q28748886 | Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model |
| Q41437305 | Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles |
| Q33585993 | Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis |
| Q41446450 | Identification of TyeA residues required to interact with YopN and to regulate Yop secretion |
| Q35111099 | Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity |
| Q34562642 | Identification of novel protein-protein interactions of Yersinia pestis type III secretion system by yeast two hybrid system |
| Q42518529 | Identification of the MxiH needle protein residues responsible for anchoring invasion plasmid antigen D to the type III secretion needle tip. |
| Q41445750 | Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis |
| Q41389173 | Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes. |
| Q36974485 | Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague |
| Q36898369 | Impassable YscP substrates and their impact on the Yersinia enterocolitica type III secretion pathway. |
| Q92893241 | Improved production of monoclonal antibodies against the LcrV antigen of Yersinia pestis using FACS-aided hybridoma selection |
| Q33483363 | In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis. |
| Q30973404 | Innate immune recognition of Yersinia pseudotuberculosis type III secretion |
| Q35096231 | Interactions and predicted host membrane topology of the enteropathogenic Escherichia coli translocator protein EspB |
| Q40454924 | Introduction to Type III Secretion Systems. |
| Q41856079 | IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri |
| Q38282188 | Key steps in type III secretion system (T3SS) towards translocon assembly with potential sensor at plant plasma membrane. |
| Q36581211 | LcrV mutants that abolish Yersinia type III injectisome function |
| Q34068346 | Length control of the injectisome needle requires only one molecule of Yop secretion protein P (YscP). |
| Q90400965 | Life After Secretion-Yersinia enterocolitica Rapidly Toggles Effector Secretion and Can Resume Cell Division in Response to Changing External Conditions |
| Q36960814 | Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine |
| Q38667595 | Lytic transglycosylases: concinnity in concision of the bacterial cell wall |
| Q35073938 | Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag |
| Q27680731 | Membrane and Chaperone Recognition by the Major Translocator Protein PopB of the Type III Secretion System of Pseudomonas aeruginosa |
| Q37823656 | Membrane targeting and pore formation by the type III secretion system translocon |
| Q28492629 | Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa |
| Q33553003 | Molecular architecture of Streptococcus pneumoniae TIGR4 pili |
| Q24670035 | Molecular model of a type III secretion system needle: Implications for host-cell sensing |
| Q30431366 | Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria |
| Q40214494 | Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells |
| Q42713418 | N-terminal type III secretion signal of enteropathogenic Escherichia coli translocator proteins |
| Q41785011 | N-terminus of IpaB provides a potential anchor to the Shigella type III secretion system tip complex protein IpaD. |
| Q39794212 | N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection |
| Q42126458 | NMR characterization of the interaction of the Salmonella type III secretion system protein SipD and bile salts |
| Q41838952 | NMR model of PrgI-SipD interaction and its implications in the needle-tip assembly of the Salmonella type III secretion system |
| Q40008433 | Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague |
| Q40451950 | Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis. |
| Q84740727 | Plague |
| Q34805666 | Plague in Guinea pigs and its prevention by subunit vaccines |
| Q38612499 | Plague: Infections of Companion Animals and Opportunities for Intervention |
| Q37150791 | Pneumonic plague pathogenesis and immunity in Brown Norway rats |
| Q35867550 | Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity |
| Q37745002 | Predictive models and correlates of protection for testing biodefence vaccines |
| Q36513899 | Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines |
| Q38131537 | Prophylaxis and therapy of plague |
| Q26823422 | Protecting against plague: towards a next-generation vaccine |
| Q33487545 | Protection against anthrax and plague by a combined vaccine in mice and rabbits |
| Q37190877 | Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine |
| Q28276443 | Protein delivery into eukaryotic cells by type III secretion machines |
| Q30318075 | Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria |
| Q27662205 | Protein refolding is required for assembly of the type three secretion needle |
| Q37332326 | Protein secretion and membrane insertion systems in bacteria and eukaryotic organelles |
| Q28501148 | Protein-protein interactions within type III secretion system-dependent pili of Rhizobium sp. strain NGR234 |
| Q41525965 | PscI is a type III secretion needle anchoring protein with in vitro polymerization capacities. |
| Q37688618 | Rational considerations about development of live attenuated Yersinia pestis vaccines |
| Q40463683 | Reassessment of MxiH subunit orientation and fold within native Shigella T3SS needles using surface labelling and solid-state NMR. |
| Q33996241 | Recognition and delivery of effector proteins into eukaryotic cells by bacterial secretion systems. |
| Q38079815 | Regulation of the Yersinia type III secretion system: traffic control |
| Q28493109 | Regulatory role of PopN and its interacting partners in type III secretion of Pseudomonas aeruginosa |
| Q35671570 | Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice |
| Q36804646 | RfaL is required for Yersinia pestis type III secretion and virulence |
| Q41307994 | Role of host cell polarity and leading edge properties in Pseudomonas type III secretion |
| Q36984033 | Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia pestis. |
| Q37416226 | Secretion by numbers: Protein traffic in prokaryotes |
| Q35133886 | Secretion signal recognition by YscN, the Yersinia type III secretion ATPase. |
| Q35846739 | Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD. |
| Q42128393 | Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation. |
| Q36190614 | Site-Directed Mutagenesis and Its Application in Studying the Interactions of T3S Components. |
| Q41439298 | Small protective fragments of the Yersinia pestis V antigen |
| Q57048274 | SsaV Interacts with SsaL to Control the Translocon-to-Effector Switch in the SPI-2 Type Three Secretion System |
| Q27660501 | Structural Basis of Chaperone Recognition of Type III Secretion System Minor Translocator Proteins |
| Q40435679 | Structural analysis of inter-genus complexes of V-antigen and its regulator and their stabilization by divalent metal ions |
| Q28732757 | Structural characterization of a novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803 |
| Q37460910 | Structural dissection of the extracellular moieties of the type III secretion apparatus |
| Q37812889 | Structural overview of the bacterial injectisome |
| Q37014297 | Structure and biophysics of type III secretion in bacteria |
| Q27340227 | Structure of a bacterial type III secretion system in contact with a host membrane in situ |
| Q38006509 | Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function |
| Q41427637 | T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague |
| Q41400721 | TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica. |
| Q30485605 | Targeting type III secretion in Yersinia pestis |
| Q34313640 | Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia |
| Q40403205 | The Amino-Terminal Part of the Needle-Tip Translocator LcrV of Yersinia pseudotuberculosis Is Required for Early Targeting of YopH and In vivo Virulence |
| Q33502747 | The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex |
| Q64075941 | The Injectisome, a Complex Nanomachine for Protein Injection into Mammalian Cells |
| Q40640251 | The LcrG Tip Chaperone Protein of the Yersinia pestis Type III Secretion System Is Partially Folded. |
| Q26767237 | The Many Faces of IpaB |
| Q47744378 | The Pseudomonas syringae HrpJ protein controls the secretion of type III translocator proteins and has a virulence role inside plant cells |
| Q28073674 | The Structure and Function of Type III Secretion Systems |
| Q35972461 | The Type III Secretion Translocation Pore Senses Host Cell Contact. |
| Q38160403 | The Yersinia pestis type III secretion system: expression, assembly and role in the evasion of host defenses |
| Q49837446 | The YscE/YscG chaperone and YscF N-terminal sequences target YscF to the Yersinia pestis type III secretion apparatus. |
| Q41425944 | The assembly of the export apparatus (YscR,S,T,U,V) of the Yersinia type III secretion apparatus occurs independently of other structural components and involves the formation of an YscV oligomer. |
| Q37993038 | The blueprint of the type-3 injectisome |
| Q28488627 | The common structural architecture of Shigella flexneri and Salmonella typhimurium type three secretion needles |
| Q27665429 | The crystal structures of the Salmonella type III secretion system tip protein SipD in complex with deoxycholate and chenodeoxycholate |
| Q34767708 | The discovery of SycO highlights a new function for type III secretion effector chaperones. |
| Q39896038 | The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding. |
| Q41447968 | The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses |
| Q36211081 | The hydrophilic translocator for Vibrio parahaemolyticus, T3SS2, is also translocated |
| Q38589273 | The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague |
| Q29617944 | The type III secretion injectisome |
| Q37756149 | The type III secretion injectisome, a complex nanomachine for intracellular 'toxin' delivery |
| Q37397923 | The type III secretion system of Pseudomonas aeruginosa: infection by injection |
| Q34011259 | The type III secretion system tip complex and translocon. |
| Q42566246 | Three-dimensional electron microscopy reconstruction and cysteine-mediated crosslinking provide a model of the type III secretion system needle tip complex. |
| Q37665331 | Timing is everything: the regulation of type III secretion |
| Q37368717 | Translational regulation of Yersinia enterocolitica mRNA encoding a type III secretion substrate |
| Q34048607 | Translocators YopB and YopD from Yersinia enterocolitica form a multimeric integral membrane complex in eukaryotic cell membranes |
| Q36744798 | Type 3 Secretion Translocators Spontaneously Assemble a Hexadecameric Transmembrane Complex |
| Q34270387 | Type III secretion in Yersinia: injectisome or not? |
| Q36969851 | Type III secretion systems and disease |
| Q38586932 | Type III secretion systems: the bacterial flagellum and the injectisome |
| Q39218275 | Type III secretion translocon assemblies that attenuate Yersinia virulence. |
| Q89950008 | Type three secretion system in Salmonella Typhimurium: the key to infection |
| Q42183752 | Ultrastructural analysis of IpaD at the tip of the nascent MxiH type III secretion apparatus of Shigella flexneri |
| Q27008415 | V-antigen homologs in pathogenic gram-negative bacteria |
| Q36950063 | Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis |
| Q60934153 | Visualization of translocons in Yersinia type III protein secretion machines during host cell infection |
| Q33964205 | Vp1659 is a Vibrio parahaemolyticus type III secretion system 1 protein that contributes to translocation of effector proteins needed to induce cytolysis, autophagy, and disruption of actin structure in HeLa cells |
| Q36638746 | What's the point of the type III secretion system needle? |
| Q21559505 | Yersinia controls type III effector delivery into host cells by modulating Rho activity |
| Q41380323 | Yersinia enterocolitica type III secretion injectisomes form regularly spaced clusters, which incorporate new machines upon activation |
| Q41441370 | Yersinia enterocolitica type III secretion of YopR requires a structure in its mRNA |
| Q37191268 | Yersinia pestis IS1541 transposition provides for escape from plague immunity |
| Q36594087 | Yersinia pestis caf1 variants and the limits of plague vaccine protection |
| Q41437577 | Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages |
| Q26747057 | Yersinia virulence factors - a sophisticated arsenal for combating host defences |
| Q41433693 | YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis |
| Q41405474 | YopK controls both rate and fidelity of Yop translocation |
| Q33731425 | YopR impacts type III needle polymerization in Yersinia species |
| Q39758533 | YscP and YscU switch the substrate specificity of the Yersinia type III secretion system by regulating export of the inner rod protein YscI. |
| Q36513832 | YscU cleavage and the assembly of Yersinia type III secretion machine complexes |
| Q30479614 | YscU recognizes translocators as export substrates of the Yersinia injectisome |
Search more.